MBX Biosciences (MBX) Times Interest Earned (2023 - 2026)
MBX Biosciences (MBX) reported Times Interest Earned of -$0.35 for Q1 2026, up 95.87% on a YoY basis from -$0.18 in Q1 2025, and up 99.87% sequentially from -$257.95 in Q4 2025.
MBX Biosciences (MBX) Times Interest Earned (2023 - 2026) Analysis & Trends
MBX Biosciences (MBX) has 4 years of Times Interest Earned data on file, last reported at -$0.35 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned rose 95.87% year-over-year to -$0.35; the trailing twelve-month figure through Mar 2026 stood at -$1.26 (up 95.12% YoY), and the FY2025 full-year result was -$1.0, up 39.02% from the prior year.
- Times Interest Earned climbed to -$0.35 in Q1 2026, from -$257.95 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$0.35 in Q1 2026 to a low of -$257.95 in Q4 2025.
- A 4-year average of -$84.11 and a median of -$8.4 in 2025 frame the typical range for Times Interest Earned.
- Across the five-year window, Times Interest Earned slumped 8362.14% in 2024 and soared 98.99% in 2025, its largest moves.
- Tracing MBX's Times Interest Earned over 4 years: stood at -$2.2 in 2023, then tumbled by 8362.14% to -$186.1 in 2024, then sank by 38.61% to -$257.95 in 2025, then surged by 99.87% to -$0.35 in 2026.
- Business Quant data shows MBX's Times Interest Earned at -$0.35 in Q1 2026, -$257.95 in Q4 2025, and -$0.63 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | MBX Biosciences | 2.96 Bn | 2.96 Bn | - | -0.35 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.35 |
| Dec 31, 2025 | -257.95 |
| Sep 30, 2025 | -0.63 |
| Jun 30, 2025 | -1.69 |
| Mar 31, 2025 | -8.40 |
| Dec 31, 2024 | -186.10 |
| Jun 30, 2024 | -166.58 |
| Mar 31, 2024 | -133.14 |
| Dec 31, 2023 | -2.20 |